[{"ATTACHMENTNAME":"244a778e-64dd-40d5-8e88-5e6ee60486f5.pdf","NEWS_DT":"2022-11-23T17:39:02.797","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Orchid Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call","SCRIP_CD":524372,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"d0713971-a80a-42c3-9e6d-8d7a305f91f2.pdf","NEWS_DT":"2022-08-17T18:19:22.14","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Transcript of Analysts/Investors Conference Call pertaining to the Financial Results for the Quarter ended June 30, 2022","SCRIP_CD":524372,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"b72a45a4-6bd0-4c6d-ae41-983544d173c9.pdf","NEWS_DT":"2022-02-24T20:21:52.243","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Transcript of Earnings conference call (Q3FY2022) held on February 18, 2022","SCRIP_CD":524372,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"}]